Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Center, Randomized, Double-Blind, Placebo (Double-Dummy) and Active-Controlled, Parallel-Group Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Herniorrhaphy

NCT06215859 is registered in ClinicalTrials.gov with Viatris Specialty LLC as lead sponsor.

NCT NCT06215859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06215859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Center, Randomized, Double-Blind, Placebo (Double-Dummy) and Active-Controlled, Parallel-Group Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Herniorrhaphy
Lead sponsor
Viatris Specialty LLC
Phase
Phase 3
Overall status
Completed
Start date
December 29, 2023
Completion date
March 12, 2025
Enrollment
579 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

acute pain, pain, post operative pain